Horlicks Brings Unilever 'Transformative' Nutritional Deal, Market Challenges
This article was originally published in The Rose Sheet
Firm's Hindustan Unilever division will merge with s GSK Consumer Healthcare India which has had total sales around €550m so far in 2018, primarily through the Horlicks and Boost brands and with nearly 90% of the revenues in India. Also will acquire 82% stake in GSK Bangladesh and other GSK commercial operations and assets outside India, paying €3.3bn in combination of cash and shares in Hindustan Unilever.
You may also be interested in...
GSK says London-based Unilever's £50bn bid for Consumer Healthcare fundamentally undervalues a business which generated sales close to £10bn last year and is expected to grow 4-6% over the medium term. The rejection has not dissuaded Unilever, however, with the company intent on stepping up its presence in the health, beauty and hygiene categories.
GSK Consumer Healthcare's sale of its Indian business has generated £0.5bn more than expected thanks to the increased value of its holding in Hindustan Unilever.
GSK commits to investing behind OTC and oral health brands in India after offloading nutrition assets to Unilever.